Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Foxard 37.5mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Cubit Healthcare

Salt Composition

Venlafaxine (37.5mg)

Overview Foxard 37.5mg Tablet ER

Anxifree 37.5mg Extended-Release Tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating symptoms like agitation, unease, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Anxifree 37.5mg ER with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon remembering; avoid skipping doses and complete the prescribed course, even with symptom improvement. Abrupt discontinuation may exacerbate symptoms. Potential side effects include queasiness, vomiting, sleeplessness, reduced appetite, nervousness, bowel irregularity, increased sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or tasks requiring alertness until the medication's effects are known. These side effects typically subside. Consult your doctor if they persist or are troublesome. Before starting Anxifree 37.5mg ER, disclose any kidney, heart, or liver conditions, or history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal thoughts to your physician.

Uses of Foxard 37.5mg Tablet ER

Mood disorders encompassing depressive and anxiety symptoms

Major Benefits of Foxard 37.5mg Tablet ER:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Foxard 37.5mg Extended-Release Tablet with food.

Common Side effects of Foxard 37.5mg Tablet ER:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Foxard 37.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 37.5mg extended-release Foxard tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.

How Foxard 37.5mg Tablet ER works:

Extended-release Foxard 37.5mg tablets elevate brain levels of serotonin and norepinephrine, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Foxard 37.5mg Extended-Release Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Foxard 37.5mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the unborn. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Foxard 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant. Close observation of newborns for drowsiness and appropriate weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Foxard 37.5mg Extended-Release Tablets due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving safety.

KidneyKidneyCAUTION

Extended-release Foxard 37.5mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Foxard 37.5mg extended-release tablets may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Foxard 37.5mg Extended-Release tablets cautiously. Dosage modification of Foxard 37.5mg Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Foxard 37.5mg Tablet ER :

Should you forget a Foxard 37.5mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Foxard 37.5mg Tablet ER

LabelValue
Chemical Category Anisole-based compound
Developing Habits No.
Treatment Category Neuroscience Central Nervous System
Actions SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Foxard 37.5mg Tablet ER

Sedation is a possible side effect of Foxard 37.5mg Tablet ER. Inform your doctor about any other sleep aids you're using before starting this medication.
Yes. Foxard 37.5mg Extended-Release tablets are psychotropic medications; psychotropic drugs are those affecting mental state, mood, and behavior.
Foxard 37.5mg Extended-Release tablets are not narcotics. Narcotics are opioid-derived drugs, such as heroin and morphine, known for their sedative effects.
Foxard 37.5mg tablets, whether ER or XR, are the same extended-release medication. This formulation slowly releases the drug, maintaining consistent therapeutic levels. Extended-release reduces the frequency of dosing.
Mirtazapine and Foxard 37.5mg Tablet ER together pose a serious risk of serotonin syndrome, a potentially life-threatening condition. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and Foxard 37.5mg ER tablets, which both raise serotonin levels, risks causing serotonin syndrome. This potentially fatal condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, unstable blood pressure, high fever, and coma. An alternative medication should be considered.
P-glycoprotein pumps Foxard 37.5mg Tablet ER out of the brain. However, some research indicates that Foxard 37.5mg Tablet ER and its metabolite can inhibit p-glycoprotein activity.
Foxard 37.5mg Extended-Release tablets are absorbed in the intestines following hepatic metabolism.
Foxard 37.5mg Extended-Release Tablets are used to treat major depressive disorder. Always consult your physician before use.
Treatment with Foxard 37.5mg Extended-Release tablets may cause sustained high blood pressure in some patients. Regular blood pressure monitoring is advised for those taking Foxard 37.5mg ER; dose reduction or treatment discontinuation may be necessary.
Constipation is a known side effect of Foxard 37.5mg ER tablets. Increase your fiber and water intake; laxatives may also help. Your doctor can advise on prevention and management. Contact your doctor if constipation persists or worsens.
Yes. Foxard 37.5mg Extended-Release tablets have been associated with weight loss in some patients. Studies show this effect increases with higher doses and longer treatment periods. Consult your doctor if this is concerning.
Foxard 37.5mg Extended-Release Tablets are not habit-forming.
Always consult your doctor before substituting a tablet for a capsule. Altering your medication without professional guidance is risky, as different formulations can affect drug release and potentially lead to treatment failure or adverse effects.
Yes, gabapentin can be used with Foxard 37.5mg ER tablets, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Foxard 37.5mg Extended-Release tablets.
While research suggests potential benefits of Foxard 37.5mg Tablet ER for fibromyalgia, it's not approved for this use. Always consult your doctor before taking it.
While not FDA-approved for nerve pain, Foxard 37.5mg Extended-Release tablets demonstrate efficacy in some research studies and are used off-label for this purpose.
Foxard 37.5mg Extended-Release tablets alter brain neurotransmitter levels, resulting in dose-dependent appetite suppression.
Experience decreased libido or impotence? Consult your doctor; alternative medications may be available. Do not discontinue Foxard 37.5mg Tablet ER without medical supervision, as this could worsen side effects.
Foxard 37.5mg Tablet ER
32
MRP 40
18% off